STOCK TITAN

Corvel Corp - CRVL STOCK NEWS

Welcome to our dedicated news page for Corvel (Ticker: CRVL), a resource for investors and traders seeking the latest updates and insights on Corvel.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Corvel's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Corvel's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.28%
Tags
none
-
News
Rhea-AI Summary
CorVel Corporation announced record revenues of $190 million for the quarter ended June 30, 2023, compared to $176 million in the same quarter of the previous year. Earnings per share also reached a record high of $1.14, compared to $0.94 in the prior year's quarter. The company's 1st generative AI initiative will be released in the September quarter, aimed at reducing repetitive tasks and providing decision support. CorVel also expanded its service offerings in the health market and strengthened its foundational systems and workflow processes. The Workers' Compensation operations saw improved performance due to operational efficiencies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.39%
Tags
-
Rhea-AI Summary
Symbeo, Inc. (CorVel): Launches New Payments Solution for Accounts Payable Invoice Automation in Partnership with Corpay, Promising Improved Security and Efficiency. President Tomika A. Russell highlights the product's benefits, including fraud detection, supplier onboarding, attrition, and vendor resolution, as well as the potential for increased market capitalization and value unlocking through tighter financial controls.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.5%
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.94%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.06%
Tags
none
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.13%
Tags
Corvel Corp

Nasdaq:CRVL

CRVL Rankings

CRVL Stock Data

4.11B
9.08M
46.89%
53.78%
2.1%
Dental Laboratories
Manufacturing
Link
United States of America
IRVINE

About CRVL

together, let's do more. corvel is a leader of risk and healthcare management solutions to employers, third party administrators, insurance companies and government agencies. we are publicly traded (nasdaq:crvl) and annual revenues exceeded $493 million in fy2015. our continued customer growth is a testament to our financial stability and our significant investments in new systems and technologies allows us to continue to deliver industry-leading solutions to the marketplace. corvel has approximately 3,500 associates who serve more than 2,000 customers through a national branch office network covering all 50 states.